Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adebrelimab (SHR-1316)”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543783
What this trial is testing

Efficacy and Safety of Low-dose Bevacizumab Plus Adebrelimab Combined With Transarterial Chemoembolization Followed by Hepatic Arterial Infusion Chemotherapy (TACE-HAIC) as First-line Treatment for Unresectable Hepatocellular Carcinoma: A Single-arm Phase 2 Trial

Who this might be right for
Adebrelimab (SHR-1316)BevacizumabHepatocellular Carcinoma (HCC)
Third Affiliated Hospital, Sun Yat-Sen University 38
Large-scale testing (Phase 3)Looking for participantsNCT07679360
What this trial is testing

Trastuzumab Rezetecan in Combination With Adebrelimab Versus Investigator's Choice of Therapy in Subjects With Residual Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07241793
What this trial is testing

Phase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)

Who this might be right for
Urothelial CarcinomaAdvanced Urothelial CarcinomaUrothelial Carcinoma Recurrent
Sun Yat-sen University 96
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07798947
What this trial is testing

A Phase II Clinical Study of SHR-7787 Injection Combined With SHR-1316 Injection in Patients With LS-SCLC

Who this might be right for
Limited-stage Small-cell Lung Cancer
Shanghai Hengrui Pharmaceutical Co., Ltd. 120
Large-scale testing (Phase 3)Not Yet RecruitingNCT05496166
What this trial is testing

The Efficiency of Surgery and Radiotherapy After SHR-1316 (Adebrelimab) and Platinum-containing Doublet Induction Therapy for Limited-stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 348
Large-scale testing (Phase 3)Not Yet RecruitingNCT06335355
What this trial is testing

A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients

Who this might be right for
Non-squamous Non-small Cell Lung Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 401
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07770672
What this trial is testing

An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging

Who this might be right for
Esophageal CancerESCC
Tan Lijie 92
Testing effectiveness (Phase 2)Looking for participantsNCT06454448
What this trial is testing

Phase Ib/II Clinical Study of Adebrelimab in Combination With Decitabine, Albumin-bound Paclitaxel, and Gemcitabine for the First-line Treatment of Metastatic Pancreatic Cancer

Who this might be right for
Adebrelimab (SHR-1316)DecitabineMetastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07035392
What this trial is testing

Adebrelimab + Chemotherapy as Neoadjuvant Therapy for Resectable NSCLC

Who this might be right for
Adebrelimab (SHR-1316)NSCLCChemotherapy
Zhangzhou Municipal Hospital 32
Testing effectiveness (Phase 2)Looking for participantsNCT06607276
What this trial is testing

Phase 2 Trial of Adjuvant Adebrelimab Combined With Capecitabine in High-Risk Resected Cholangiocarcinoma: ACHIEVE

Who this might be right for
Cholangiocarcinoma CancerAdebrelimab (SHR-1316)
The First Affiliated Hospital with Nanjing Medical University 122
Testing effectiveness (Phase 2)Looking for participantsNCT06506292
What this trial is testing

A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC)

Who this might be right for
Adebrelimab (SHR-1316)XELOXGC/GEJC
Tianjin Medical University Cancer Institute and Hospital 25
Large-scale testing (Phase 3)Looking for participantsNCT07522151
What this trial is testing

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Locally Advanced Gastric or Gastroesophageal Junction Cancer
Shanghai Shengdi Pharmaceutical Co., Ltd 874
Large-scale testing (Phase 3)Looking for participantsNCT06879145
What this trial is testing

Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)

Who this might be right for
Muscular Invasive Bladder Cancer (MIBC)
Suzhou Suncadia Biopharmaceuticals Co., Ltd. 840
Testing effectiveness (Phase 2)Looking for participantsNCT06869213
What this trial is testing

A Single-arm, Open, Single-center Exploratory Study of Adebrelimab (SHR-1316) in Combination With Chemotherapy for the Perioperative Treatment of Locally Advanced Resectable Esophageal Squamous Carcinoma

Who this might be right for
Esophageal Cancer (EsC)
Peking University Cancer Hospital & Institute 30